US: ACNNF - AusCann Group Holdings Ltd

Yield per half year: +26.67%

Share chart AusCann Group Holdings Ltd


About

AusCann Group Holdings Ltd engages in the development and commercialization of cannabinoid-derived therapeutic products for humans and animals in Australia and internationally. Its principal product includes the novel tetrahydrocannabinol and cannabidiol (THC/CBD), a powder-based hard-shell capsules based on AusCann's Neuvis platform for the treatment of pain and related indications. The company is also involved in the research and development of medicinal cannabis. It offers its products to healthcare professionals and veterinarians.

More details
AusCann Group Holdings Ltd is based in West Perth, Australia.

Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://auscann.com.au
Цена ао 0.0038
Change price per day: 0% (0.0038)
Change price per week: -38.71% (0.0062)
Change price per month: -72.06% (0.0136)
Change price per 3 month: -69.6% (0.0125)
Change price per half year: +26.67% (0.003)
Change price per year: +22.58% (0.0031)
Change price per 3 year: -95.03% (0.0765)
Change price per 5 year: -98.54% (0.26)
Change price per year to date: +137.5% (0.0016)

Underestimation

Title Value Grade
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
Total: 2.5

Efficiency

Title Value Grade
ROA, % 0 0
ROE, % 0 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 1.42

Debt

Title Value Grade
Debt/EBITDA 0 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 131.31 10
Yield Ebitda, % 129.35 10
Yield EPS, % 627.27 10
Total: 7.2

Head Job title Payment Year of birth
Mr. Christopher Mews A.C.I.S., B. Bus, C.P.A. Chief Financial Officer
Ms. Rachel Jelleff Kerr Company Secretary

Address: Australia, West Perth, 1202 Hay Street - open in Google maps, open in Yandex maps
Website: https://auscann.com.au